ArticleCurrent oncology (Toronto, Ont.)2022

In Silico Identification and Validation of Cuproptosis-Related LncRNA Signature as a Novel Prognostic Model and Immune Function Analysis in Colon Adenocarcinoma.

Yue Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.